Medtronic Cardiac Ablation Solutions
Clinical trials sponsored by Medtronic Cardiac Ablation Solutions, explained in plain language.
Division of Medtronic making devices for cardiac ablation procedures.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart device registry tracks Real-World results for 1,950 AFib patients Results expected Oct 2026 (estimated)
- New heart catheter aims to stop dangerous rhythms in their tracks Results expected Nov 2026 (estimated)
- New catheter aims to tame irregular heartbeat Results expected Mar 2027 (estimated)
- New device aims to zap away atrial fibrillation Results expected Mar 2027 (estimated)
- New heart procedure tracked for 3 years in 580 patients Results expected Apr 2027 (estimated)
-
New heart catheter aims to stop dangerous rhythms in their tracks
Disease control Recruiting nowThis study is testing a new device called the Sphere-9 catheter, used with the Affera mapping system, to treat ventricular tachycardia (VT) — a fast, dangerous heart rhythm. The procedure uses heat to destroy small areas of scarred heart tissue that cause the abnormal rhythm. The…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New heart catheter aims to tame Life-Threatening rhythm disorder
Disease control Recruiting nowThis study tests a new device (Sphere-9 catheter and Affera system) to treat ventricular tachycardia, a fast, dangerous heart rhythm, in 260 adults who have had a heart attack. Participants must have had repeated episodes despite medication or a defibrillator. The goal is to see …
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New heart procedure tracked for 3 years in 580 patients
Disease control Recruiting nowThis study follows 580 adults with atrial fibrillation who are treated with the PulseSelect PFA system, a device that uses electrical pulses to fix irregular heartbeats. Researchers will monitor participants for 36 months to see how well the procedure prevents heart rhythm proble…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New device aims to tame stubborn atrial fibrillation after first ablation fails
Disease control Recruiting nowThis study tests a new catheter system (Sphere-9) for a repeat heart ablation procedure in 400 people whose atrial fibrillation came back after an earlier ablation. The procedure uses radiofrequency and pulsed field energy to correct faulty heart signals. Participants will be fol…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Freezing away AF: new study tracks 3-Year success of cryoablation
Disease control Recruiting nowThis study follows 200 people with paroxysmal atrial fibrillation (AF) who undergo a procedure using a freezing catheter to isolate the pulmonary veins. The goal is to see how many remain free from AF, atrial flutter, or atrial tachycardia for up to 3 years, and to track safety e…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New catheter aims to tame irregular heartbeat
Disease control Recruiting nowThis study tests a new device called the SpherePVI catheter, which uses heat to isolate the veins that trigger atrial fibrillation. About 100 adults with symptomatic AF who haven't responded to medication will be enrolled. The main goals are to see if the procedure is safe and ca…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New device aims to zap away atrial fibrillation
Disease control Recruiting nowThis study tests a new catheter system called SpherePVI that uses heat to destroy tiny areas of heart tissue causing atrial fibrillation (an irregular heartbeat). About 150 people with symptomatic atrial fibrillation will undergo the procedure. The goal is to see if the device ca…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New heart device registry tracks Real-World results for 1,950 AFib patients
Knowledge-focused Recruiting nowThis registry is following 1,950 people with atrial fibrillation who are treated with the PulseSelect PFA system, a device that uses electrical pulses to correct irregular heartbeats. Researchers are tracking how well the procedure prevents AFib from coming back and how often ser…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New heart device registry aims to track Real-World results for AFib patients
Knowledge-focused Recruiting nowThis registry will follow 540 people with atrial fibrillation who are treated with the Affera ablation device. Researchers want to see how well the device stops irregular heart rhythms and how safe it is in everyday medical practice. The study is observational, meaning patients g…
Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC